# CSF2

## Overview
The CSF2 gene encodes the cytokine granulocyte-macrophage colony-stimulating factor (GM-CSF), which is pivotal in hematopoiesis and immune regulation. GM-CSF is a cytokine that primarily functions to stimulate the proliferation and differentiation of hematopoietic progenitor cells into granulocytes and macrophages, essential components of the immune system (Burkhardt2012Differential). As a homodimeric protein, GM-CSF is categorized as a cytokine and is involved in various cellular processes, including the activation of macrophages and neutrophils, which are crucial for immune defense and inflammatory responses (Balloy2015Normal). The protein's structure, characterized by a compact, globular shape, is essential for its biological activity and interaction with other molecules (Cui2020Mapping). GM-CSF also plays a significant role in the central nervous system, where it helps regulate microglial function and maintain homeostasis, thereby contributing to neuroprotection (Chitu2019Microglial). The gene's expression and the protein's activity are implicated in various pathological conditions, including cancer and inflammatory diseases, highlighting its clinical significance (Li2022Colony‑stimulating; Ushach2016Biological).

## Structure
The CSF2 gene encodes the granulocyte-macrophage colony-stimulating factor (GM-CSF), a cytokine involved in hematopoiesis. The primary structure of GM-CSF consists of a polypeptide chain of 127 amino acids, following cleavage of a precursor protein (Wong1985Human). The secondary structure includes alpha-helices and beta-sheets, contributing to its overall stability and function (Cui2020Mapping). The tertiary structure of GM-CSF forms a compact, globular shape, which is crucial for its biological activity (Cui2020Mapping).

GM-CSF functions as a homodimer, representing its quaternary structure, which is essential for its role in stimulating the growth and differentiation of hematopoietic progenitor cells (Wong1985Human). The protein is subject to post-translational modifications, including glycosylation, which influences its stability and activity (Wong1985Human). Glycosylation sites are potential contributors to the molecular heterogeneity observed in GM-CSF (Wong1985Human).

The protein's interaction with heparin is pH-dependent, with stronger binding at acidic pH due to increased flexibility and accessibility of the binding pocket, involving key residues such as His15, His83, and His87 (Cui2020Mapping).

## Function
CSF2, also known as granulocyte-macrophage colony-stimulating factor (GM-CSF), is a cytokine that plays a crucial role in the regulation of immune and inflammatory responses. In healthy human cells, CSF2 is essential for the survival, proliferation, and differentiation of hematopoietic progenitor cells, particularly those that give rise to granulocytes and macrophages (Burkhardt2012Differential). This cytokine is involved in the activation and function of macrophages and neutrophils, which are key players in the body's defense against infections and in the inflammatory response (Balloy2015Normal).

CSF2 is also implicated in the regulation of microglial function within the central nervous system. It helps maintain microglial homeostasis and is involved in balancing oxidative stress and inflammation, which is crucial for protecting against neurodegenerative conditions (Chitu2019Microglial). The protein is active in various cellular pathways, including the Jak/STAT signaling pathway, which is important for delaying neutrophil apoptosis and enhancing their function during immune responses (Balloy2015Normal).

Overall, CSF2 is a key factor in modulating immune cell activity and maintaining the balance between pro-inflammatory and anti-inflammatory processes, contributing to both local and systemic immune responses.

## Clinical Significance
Alterations in the expression of the CSF2 gene, also known as colony-stimulating factor 2, have been implicated in various diseases and conditions. In small-cell lung cancer (SCLC), CSF2 is a key regulator of phenotypic plasticity and intratumoral heterogeneity. It influences the transformation between different cell phenotypes and affects drug sensitivity through the p-STAT3/MYC signaling pathway. High levels of CSF2 expression are associated with increased resistance to certain drugs, while its inhibition can enhance drug sensitivity and promote phenotypic conversion from non-neuroendocrine to neuroendocrine types (Li2022Colony‑stimulating).

In the context of basal-like breast cancer (BLBC), CSF2 expression is upregulated due to the influence of the HIST1H1B gene, which binds to the CSF2 promoter. This upregulation is linked to increased tumorigenicity and poor prognosis, as CSF2 plays a role in suppressing the immune response and regulating the stem cell phenotype in tumors (Liao2021HIST1H1B).

Beyond cancer, altered CSF2 expression is associated with inflammatory diseases such as rheumatoid arthritis and asthma. Overexpression can lead to chronic inflammation, while mutations affecting its normal interactions may contribute to conditions like pulmonary alveolar proteinosis (Ushach2016Biological).

## Interactions
CSF2, also known as Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF), is involved in various protein interactions that influence cellular processes. It interacts with the JAK2 and STAT3 signaling pathways, playing a significant role in tumor angiogenesis and vascularization. This interaction is crucial in small-cell lung cancer (SCLC), where CSF2 regulates the p-STAT3/MYC pathway, affecting phenotypic plasticity and drug resistance (Li2022Colony‑stimulating).

In the context of gliomas, CSF2 is implicated in activating antiapoptotic and proangiogenic pathways by activating the STAT-3 transcription factor or increasing VEGF/VEGFR expression (Li2022Colony‑stimulating). CSF2 also interacts with the CSF2Rb-STAT5 signaling pathway, which is involved in compensatory macrophage activation in breast-to-brain metastasis. This interaction promotes tumor growth and resistance to CSF1R inhibition (Klemm2021Compensatory).

CSF2's role in macrophage transition is highlighted in sepsis-induced acute kidney injury, where it promotes the transition from M1 to M2 macrophages through the activation of the p-Stat5 pathway (Li2020Csf2). These interactions underscore CSF2's involvement in immune modulation and tumor progression.


## References


[1. (Balloy2015Normal) Viviane Balloy, Hugo Varet, Marie-Agnès Dillies, Caroline Proux, Bernd Jagla, Jean-Yves Coppée, Olivier Tabary, Harriet Corvol, Michel Chignard, and Loïc Guillot. Normal and cystic fibrosis human bronchial epithelial cells infected with pseudomonas aeruginosa exhibit distinct gene activation patterns. PLOS ONE, 10(10):e0140979, October 2015. URL: http://dx.doi.org/10.1371/journal.pone.0140979, doi:10.1371/journal.pone.0140979. This article has 18 citations and is from a peer-reviewed journal.](https://doi.org/10.1371/journal.pone.0140979)

2. (Klemm2021Compensatory) Compensatory CSF2-driven macrophage activation promotes adaptive resistance to CSF1R inhibition in breast-to-brain metastasis. This article has 1 citations.

3. (Chitu2019Microglial) Microglial homeostasis requires balanced CSF-1/CSF-2 receptor signaling. This article has 0 citations.

[4. (Ushach2016Biological) Irina Ushach and Albert Zlotnik. Biological role of granulocyte macrophage colony-stimulating factor (gm-csf) and macrophage colony-stimulating factor (m-csf) on cells of the myeloid lineage. Journal of Leukocyte Biology, 100(3):481–489, June 2016. URL: http://dx.doi.org/10.1189/jlb.3ru0316-144r, doi:10.1189/jlb.3ru0316-144r. This article has 344 citations and is from a peer-reviewed journal.](https://doi.org/10.1189/jlb.3ru0316-144r)

[5. (Li2020Csf2) Yiming Li, Pan Zhai, Yawen Zheng, Jing Zhang, John A. Kellum, and Zhiyong Peng. Csf2 attenuated sepsis-induced acute kidney injury by promoting alternative macrophage transition. Frontiers in Immunology, July 2020. URL: http://dx.doi.org/10.3389/fimmu.2020.01415, doi:10.3389/fimmu.2020.01415. This article has 29 citations and is from a peer-reviewed journal.](https://doi.org/10.3389/fimmu.2020.01415)

[6. (Burkhardt2012Differential) Jana Burkhardt, Holger Kirsten, Grit Wolfram, Elfi Quente, and Peter Ahnert. Differential allelic expression of il13 and csf2 genes associated with asthma. Genetics and Molecular Biology, 35(3):567–574, August 2012. URL: http://dx.doi.org/10.1590/s1415-47572012005000055, doi:10.1590/s1415-47572012005000055. This article has 11 citations and is from a peer-reviewed journal.](https://doi.org/10.1590/s1415-47572012005000055)

[7. (Cui2020Mapping) Jennifer Y. Cui, Fuming Zhang, Lukasz Nierzwicki, Giulia Palermo, Robert J. Linhardt, and George P. Lisi. Mapping the structural and dynamic determinants of ph-sensitive heparin binding to granulocyte macrophage colony stimulating factor. Biochemistry, 59(38):3541–3553, September 2020. URL: http://dx.doi.org/10.1021/acs.biochem.0c00538, doi:10.1021/acs.biochem.0c00538. This article has 5 citations and is from a peer-reviewed journal.](https://doi.org/10.1021/acs.biochem.0c00538)

[8. (Wong1985Human) Gordon G. Wong, JoAnn S. Witek, Patricia A. Temple, Kathleen M. Wilkens, Anne C. Leary, Deborah P. Luxenberg, Simon S. Jones, Eugene L. Brown, Robert M. Kay, Elizabeth C. Orr, Charles Shoemaker, David W. Golde, Randal J. Kaufman, Rodney M. Hewick, Elizabeth A. Wang, and Steven C. Clark. Human gm-csf: molecular cloning of the complementary dna and purification of the natural and recombinant proteins. Science, 228(4701):810–815, May 1985. URL: http://dx.doi.org/10.1126/science.3923623, doi:10.1126/science.3923623. This article has 780 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1126/science.3923623)

[9. (Li2022Colony‑stimulating) Hui Li, Rui Zhong, Chunying He, Chenchen Tang, Heran Cui, Rixin Li, Yan Liu, Shaowei Lan, and Ying Cheng. Colony‑stimulating factor csf2 mediates the phenotypic plasticity of small‑cell lung cancer by regulating the p‑stat3/myc pathway. Oncology Reports, May 2022. URL: http://dx.doi.org/10.3892/or.2022.8333, doi:10.3892/or.2022.8333. This article has 8 citations and is from a peer-reviewed journal.](https://doi.org/10.3892/or.2022.8333)

[10. (Liao2021HIST1H1B) Ruocen Liao, Xingyu Chen, Qianhua Cao, Yifan Wang, Zhaorui Miao, Xingyu Lei, Qianjin Jiang, Jie Chen, Xuebiao Wu, Xiaoli Li, Jun Li, and Chenfang Dong. Hist1h1b promotes basal-like breast cancer progression by modulating csf2 expression. Frontiers in Oncology, October 2021. URL: http://dx.doi.org/10.3389/fonc.2021.780094, doi:10.3389/fonc.2021.780094. This article has 9 citations and is from a peer-reviewed journal.](https://doi.org/10.3389/fonc.2021.780094)